Breast Cancer 'Memory Vaccine' Shows Promise: Could End Annual Mammograms Within 5 Years
A groundbreaking mRNA vaccine designed to train the immune system to recognize and destroy breast cancer cells before they form tumors has shown remarkable results in early human trials. Experts predict that within a decade, an annual shot could replace routine mammograms for millions of women, shifting the focus from early detection to outright prevention. The therapy, which triggers 'immune memory' against common breast cancer proteins, has eliminated microscopic tumors in 90% of high-risk participants, raising hopes for a future where the disease is eradicated before it even begins.